- Biopharm Portal
Octet system users are at the forefront of research across a range of applications. Read how real-world scientists are improving screening efficiency, increasing sample capacity and generating higher quality data.
KBI Biopharma developed a variety of Octet-based potency assays to accelerate their target to phase 1 clinical trials timeline. Important factors when developing these dual-binding assays will be discussed.
diSPR with Pioneer systems enables characterization of interactions that can’t be done with traditional SPR. Get affinity and kinetics data from primary screens, analyze unstable targets, assay a wider range of molecules and more.
12 hours of unattended run time.
Temperature control down
to 15 °C!